The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of lenvatinib in combination with GEMOX chemotherapy for advanced intrahepatic cholangiocarcinoma.
 
Guo-Ming Shi
No Relationships to Disclose
 
Zhou Jian
No Relationships to Disclose
 
Jia Fan
No Relationships to Disclose
 
Xiao-Yong Huang
No Relationships to Disclose
 
Dong Wu
No Relationships to Disclose
 
Fei Liang
No Relationships to Disclose
 
Jia-Cheng Lu
No Relationships to Disclose
 
Guo-Huan Yang
No Relationships to Disclose
 
Yi Chen
No Relationships to Disclose
 
Ning-Ling Ge
No Relationships to Disclose
 
Yuan Ji
No Relationships to Disclose
 
YY Hou
No Relationships to Disclose
 
Hui-Chuan Sun
No Relationships to Disclose
 
Shuang-Jian Qiu
No Relationships to Disclose
 
Qing-Hai Ye
No Relationships to Disclose
 
Xiao-Wu Huang
No Relationships to Disclose
 
Ying-Hong Shi
No Relationships to Disclose
 
Qiang Gao
No Relationships to Disclose
 
Xin-Rong Yang
No Relationships to Disclose
 
Zheng Wang
No Relationships to Disclose